Share on StockTwits

Aceto (NASDAQ:ACET) VP Steven Rogers unloaded 2,333 shares of the stock on the open market in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $17.58, for a total transaction of $41,014.14. Following the completion of the transaction, the vice president now directly owns 13,500 shares of the company’s stock, valued at approximately $237,330. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Singular Research cut their price target on shares of Aceto from $24.00 to $22.00 in a research note on Tuesday, May 20th. They now have a “buy” rating on the stock. Analysts at Sidoti upgraded shares of Aceto from a “neutral” rating to a “buy” rating in a research note on Monday, May 19th.

Shares of Aceto (NASDAQ:ACET) opened at 17.60 on Friday. Aceto has a 52 week low of $12.40 and a 52 week high of $25.25. The stock has a 50-day moving average of $19.66 and a 200-day moving average of $20.5. The company has a market cap of $505.6 million and a price-to-earnings ratio of 17.03.

Aceto (NASDAQ:ACET) last released its earnings data on Thursday, May 8th. The company reported $0.19 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.28 by $0.09. The company had revenue of $124.83 million for the quarter, compared to the consensus estimate of $136.70 million. The company’s quarterly revenue was down 17.3% on a year-over-year basis. Analysts expect that Aceto will post $1.00 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, June 27th. Investors of record on Thursday, June 12th will be given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend is Tuesday, June 10th.

Aceto Corporation (NASDAQ:ACET) is primarily engaged in the sourcing, regulatory support, quality assurance, marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.